The value of combining the radiosensitizer misonidazole with cyclophosphamide in treating the murine Lewis lung tumor
- 1 March 1982
- journal article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 8 (3-4) , 651-653
- https://doi.org/10.1016/0360-3016(82)90705-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Enhanced cell killing in lewis lung carcinoma and a human pancreatic-carcinoma xenograft by the combination of cytotoxic drugs and misonidazoleBritish Journal of Cancer, 1981
- In vivo combination of misonidazole and the chemotherapeutic agent CCNUBritish Journal of Cancer, 1981
- In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: methotrexate, 5-fluorouracil and adriamycinBritish Journal of Cancer, 1980
- Combination therapy of a solid murine tumor with cyclophosphamide and radiation: The effects of time, dose and assay methodInternational Journal of Radiation Oncology*Biology*Physics, 1979
- Distribution and tumour cytotoxicity of the radiosensitizer misonidazole (Ro-07-0582) in C57 miceBritish Journal of Cancer, 1979
- Radiobiological hypoxia of a transplanted rat tumour and the effect of treatment with cyclophosphamidePublished by Elsevier ,1978
- The toxicity of the radiosensitizer misonidazole towards hypoxic cellsin vitro: a model for mouse and manThe British Journal of Radiology, 1978
- Combined radiotherapy-chemotherapy of lewis lung carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1978
- Radiosensitizers of hypoxic cells in solid tumoursCancer Treatment Reviews, 1976
- Hypoxic Sensitizers: Radiobiological Studies at the Cellular LevelRadiology, 1975